INTERNATIONAL BUSINESS MACHINES CORPORATION
|
(Exact name of registrant as specified in its charter)
|
New York
|
|
13-0871985
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
Large accelerated filer
|
☒ |
Accelerated filer
|
☐ | |
Non-accelerated filer
|
☐ |
Smaller reporting company
|
☐ | |
Emerging growth company
|
☐ |
CALCULATION OF REGISTRATION FEE
|
|||||||||||||||||
Title of securities
to be registered
|
Amount to be
registered
|
Proposed maximum
offering price
per share
|
Proposed maximum
aggregate offering
price
|
Amount of
registration fee
|
|||||||||||||
Capital Stock, par value $.20 per share
|
29,703,694 | (1) |
$
|
139.95
|
(2)
|
$
|
4,157,031,975.30
|
(2)
|
$ |
|
503,832.28
|
|
1.
|
Based on (i) the number of shares exchangeable for restricted shares outstanding immediately prior to the transaction contemplated by the Agreement and Plan of Merger, dated as of October 28, 2018, by and among International Business Machines Corporation (“IBM”), Socrates Acquisition Corp. (“Merger Sub”), a wholly owned subsidiary of IBM, and Red Hat, Inc. (“Red Hat”), as such agreement may be amended from time to time (the “Merger Agreement”, and the transaction contemplated therein, the “Merger”) (or 362,124) pursuant to the benefit plans listed above as of July 8, 2019, multiplied by an exchange ratio to reflect the number of shares of IBM capital stock for which such restricted shares are exchangeable pursuant to the Merger Agreement plus (ii) the number of shares exchangeable for service-based restricted stock units (“RSUs”) outstanding immediately prior to the Merger (or 3,810,754) pursuant to the benefit plans listed above as of July 8, 2019, multiplied by an exchange ratio to reflect the number of shares of IBM capital stock for which such RSUs are exchangeable pursuant to the Merger Agreement plus (iii) the number of shares exchangeable for performance-based restricted stock units (“PSUs”) outstanding immediately prior to the Merger (or 576,002) pursuant to the benefit plans listed above as of July 8, 2019, multiplied by an exchange ratio to reflect the number of shares of IBM capital stock for which such PSUs are exchangeable pursuant to the Merger Agreement plus (iv) the number of shares that remain available for issuance pursuant to the benefit plans listed above (“Residual Shares”) as of July 8, 2019, multiplied by an exchange ratio to reflect the number of shares of IBM capital stock for which such Residual Shares are exchangeable pursuant to the Merger Agreement.
|
2.
|
Estimated solely for the purpose of determining the registration fee in accordance with Rule 457(h) under the Securities Act of 1933 on the basis of $139.95 per share of IBM capital stock issuable for each restricted share, each share subject to an RSU and each Residual Share under the benefit plans listed above, which is the average of the high and low prices of the IBM capital stock on the New York Stock Exchange on July 2, 2019, in each case, after taking into account the exchanges described in note (1).
|
Item 1.
|
Plan Information.
|
Item 2.
|
Registrant Information and Employee Plan Annual Information.
|
Item 3.
|
Incorporation of Documents by Reference.
|
· |
The Annual Report of IBM on Form 10-K for the fiscal year ended December 31, 2018, filed with the Commission on February 26, 2019.
|
· |
The portions of IBM’s Definitive Proxy Statement on Schedule 14A for the 2019 annual meeting of stockholders filed on March 11, 2019 that are incorporated by reference in the Annual Report on Form 10-K for the year ended December 31, 2018.
|
· |
The Quarterly Report of IBM on Form 10-Q, filed with the Commission on April 30, 2019.
|
· |
The Current Reports of IBM on Form 8-K, or filed portions of those reports, filed (but not portions of those reports which were furnished) with the Commission on January 3, 2019, January 22, 2019, January 23, 2019, January 30, 2019, February 1, 2019, February 5, 2019, February 26, 2019, March 27, 2019, April 4, 2019 (first
|
report), April 16, 2019, April 17, 2019, May 3, 2019, May 6, 2019, May 14, 2019 and May 17, 2019.
|
· |
The description of IBM’s capital stock contained in IBM’s registration statements filed pursuant to Section 12 of the Exchange Act, and any amendment or report filed for the purpose of updating any such description.
|
Item 4.
|
Description of Securities.
|
Item 5.
|
Interests of Named Experts and Counsel.
|
Item 6.
|
Indemnification of Directors and Officers.
|
Item 7.
|
Exemption from Registration Claimed.
|
Item 8.
|
Exhibits.
|
Exhibit Number
|
Description
|
|
4.1
|
||
4.2
|
||
4.3
|
||
4.4
|
||
4.5
|
||
4.6
|
||
4.7 | ||
5.1
|
||
23.1
|
||
23.2
|
||
24.1
|
||
24.2
|
Item 9.
|
Undertakings.
|
INTERNATIONAL BUSINESS MACHINES CORPORATION
|
||||
|
By:
|
/s/ Christina M. Montgomery | ||
Name: | Christina M. Montgomery | |||
Title: | Vice President, Assistant General Counsel and Secretary | |||
Signature
|
Title
|
|
* | Chairman, President and Chief Executive Officer | |
Virginia M. Rometty
|
(Principal Executive Officer)
|
|
* | Senior Vice President and Chief Financial | |
James J. Kavanaugh
|
Officer (Principal Financial Officer)
|
|
* | Vice President and Controller | |
Robert F. Del Bene
|
(Principal Accounting Officer)
|
|
* |
Director
|
|
Michael L. Eskew
|
|
|
*
|
Director
|
|
David N. Farr
|
||
*
|
Director
|
|
Alex Gorsky
|
||
*
|
Director
|
|
Michelle Howard
|
||
*
|
Director
|
|
Shirley Ann Jackson
|
||
*
|
Director
|
|
Andrew N. Liveris
|
||
*
|
Director
|
|
Martha E. Pollack
|
||
*
|
Director
|
|
Joseph R. Swedish
|
||
*
|
Director
|
|
Sidney Taurel
|
||
*
|
Director
|
|
Peter R. Voser
|
||
*
|
Director
|
|
Frederick H. Waddell
|
|
By:
|
/s/ Christina M. Montgomery | ||
Name: | Christina M. Montgomery | |||
Title: | Attorney-in-Fact | |||
Very truly yours,
|
||||
|
|
/s/ CHRISTINA M. MONTGOMERY | ||
CHRISTINA M. MONTGOMERY, ESQ. | ||||
VICE PRESIDENT, ASSISTANT GENERAL | ||||
COUNSEL AND SECRETARY |
|
|
/s/ Virginia M. Rometty | ||
Virginia M. Rometty | ||||
Chairman, President and Chief Executive Officer |
|
|
/s/ James J. Kavanaugh | ||
James J. Kavanaugh | ||||
Senior Vice President and Chief Financial Officer |
|
|
/s/ Michael L. Eskew | |
Director | |||
/s/ David N. Farr | |||
Director | |||
/s/ Alex Gorsky | |||
Director | |||
/s/ Michelle J. Howard | |||
Director | |||
/s/ Shirley Ann Jackson | |||
Director | |||
/s/ Andrew N. Liveris | |||
Director | |||
/s/ Martha E. Pollack | |||
Director | |||
/s/ Joseph R. Swedish | |||
Director | |||
/s/ Sidney Taurel | |||
Director | |||
/s/ Peter R. Voser | |||
Director | |||
/s/ Frederick H. Waddell | |||
Director |
|
By: |
/s/ Christina M. Montgomery
|
|
|
Christina M. Montgomery
|
||
|
Secretary
|